Solexa Ltd. Granted European Patent On Use Of Single Molecules For Sequencing

Solexa, Inc. (Nasdaq:SLXA) today announced that the European Patent Office has granted the company a key patent covering the use of single molecules for DNA analysis. This granted patent, EP1105529B1, further strengthens Solexa's intellectual property (IP) portfolio, which consists of some of the earliest and most fundamental patents and applications addressing the use of both single molecules and amplified colonies of single molecules for genetic analysis applications, including DNA sequencing and gene expression analysis.